Abstract
ThyroidVol. 19, No. 11 Editorials and CommentaryHighlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 RevisionLeonard WartofskyLeonard WartofskySearch for more papers by this authorPublished Online:4 Nov 2009https://doi.org/10.1089/thy.2009.1599AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByKlassifikation der Schilddrüsensonografie – Vor- und Nachteile einzelner Stratifizierungssysteme12 July 2022 | Journal für Klinische Endokrinologie und Stoffwechsel, Vol. 41Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma18 July 2020 | European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, No. 2The Bethesda System for Reporting Thyroid Cytology (TBSRTC): From look‐backs to look‐ahead30 January 2020 | Diagnostic Cytopathology, Vol. 167Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration18 December 2018 | Frontiers in Endocrinology, Vol. 9The Thyroid Nodule: Evaluation, Risk of Malignancy, and Management20 September 2016Ultrasound of the Neck Lymph Nodes20 September 2016Thyroid CancerEvaluation and management of thyroid nodules with atypia/follicular lesion of undetermined significance on fine-needle aspirationInternational Journal of Endocrine Oncology, Vol. 2, No. 4High TPOAb Levels (>1300 IU/mL) Indicate Multifocal PTC in Hashimoto’s Thyroiditis Patients and Support Total Thyroidectomy27 April 2015 | Otolaryngology–Head and Neck Surgery, Vol. 153, No. 1Insulin resistance is another factor that increases the risk of recurrence in patients with thyroid cancer11 September 2014 | Endocrine, Vol. 48, No. 3Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation1 April 2013 | Cytopathology, Vol. 25, No. 2CLM3, a Multitarget Tyrosine Kinase Inhibitor With Antiangiogenic Properties, Is Active Against Primary Anaplastic Thyroid Cancer In Vitro and In VivoThe Journal of Clinical Endocrinology & Metabolism, Vol. 99, No. 4Low- or High-Dose Radioiodine Remnant Ablation for Differentiated Thyroid Carcinoma: A Meta-AnalysisThe Journal of Clinical Endocrinology & Metabolism, Vol. 98, No. 4CLM94, a Novel Cyclic Amide with Anti-VEGFR-2 and Antiangiogenic Properties, Is Active against Primary Anaplastic Thyroid Cancer in Vitro and in VivoThe Journal of Clinical Endocrinology & Metabolism, Vol. 97, No. 4Emerging Therapies in Sight for the Fight against Dedifferentiated Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, Vol. 96, No. 2Risk groups in differentiated thyroid carcinomasActa Otorrinolaringologica (English Edition), Vol. 62, No. 1Grupos de riesgo en carcinomas diferenciados de tiroidesActa Otorrinolaringológica Española, Vol. 62, No. 1Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer10 November 2010 | Cochrane Database of Systematic Reviews, Vol. 160Recombinant Human Thyrotropin in Thyroid Remnant Ablation with 131-Iodine in High-Risk Patients Pedro Weslley Rosario, Arthur Cezar Malard Xavier, and Maria Regina Calsolari9 November 2010 | Thyroid, Vol. 20, No. 11Thyroid nodules and evaluation of thyroid cancer risk31 December 2015 | Australasian Journal of Ultrasound in Medicine, Vol. 13, No. 4The Revised American Thyroid Association Management Guidelines 2009 for Patients with Differentiated Thyroid Cancer: an Evidence-Based Risk-Adapted ApproachClinical Oncology, Vol. 22, No. 6Salivary Gland Malignancy and Radioiodine Therapy for Thyroid Cancer Joanna Klubo-Gwiezdzinska, Douglas Van Nostrand, Kenneth D. Burman, Vasyl Vasko, Stanley Chia, Tom Deng, Kanchan Kulkarni, and Leonard Wartofsky16 June 2010 | Thyroid, Vol. 20, No. 6Development of a Sensitive and Specific Quantitative Reverse Transcription-Polymerase Chain Reaction Assay for Blood Thyroglobulin Messenger Ribonucleic Acid in the Follow-Up of Patients with Differentiated Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, Vol. 95, No. 4 Volume 19Issue 11Nov 2009 InformationCopyright 2009, Mary Ann Liebert, Inc.To cite this article:Leonard Wartofsky.Highlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 Revision.Thyroid.Nov 2009.1139-1143.http://doi.org/10.1089/thy.2009.1599Published in Volume: 19 Issue 11: November 4, 2009PDF download
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call